148 related articles for article (PubMed ID: 33163262)
1. SHCBP1 regulates STAT3/c-Myc signaling activation to promote tumor progression in penile cancer.
Mo M; Tong S; Yin H; Jin Z; Zu X; Hu X
Am J Cancer Res; 2020; 10(10):3138-3156. PubMed ID: 33163262
[TBL] [Abstract][Full Text] [Related]
2. RGS20 Promotes Tumor Progression through Modulating PI3K/AKT Signaling Activation in Penile Cancer.
Shi D; Tong S; Han H; Hu X
J Oncol; 2022; 2022():1293622. PubMed ID: 35498542
[TBL] [Abstract][Full Text] [Related]
3. SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis.
Xu N; Wu YP; Yin HB; Chen SH; Li XD; Xue XY; Gou X
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1953-1969. PubMed ID: 32447485
[TBL] [Abstract][Full Text] [Related]
4. High serum CCL20 is associated with tumor progression in penile cancer.
Mo M; Tong S; Huang W; Cai Y; Zu X; Hu X
J Cancer; 2020; 11(23):6812-6822. PubMed ID: 33123272
[TBL] [Abstract][Full Text] [Related]
5. Serum CXCL5 level is associated with tumor progression in penile cancer.
Mo M; Li Y; Hu X
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33458757
[TBL] [Abstract][Full Text] [Related]
6. Serum CXCL13 Level is Associated with Tumor Progression and Unfavorable Prognosis in Penile Cancer.
Mo M; Tong S; Li T; Zu X; Hu X
Onco Targets Ther; 2020; 13():8757-8769. PubMed ID: 32943882
[TBL] [Abstract][Full Text] [Related]
7. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of SHCBP1 Inhibits Proliferation, Migration, and Invasion in Human Nasopharyngeal Carcinoma Cells.
Zhang T; He X; Yu G; He Z
Evid Based Complement Alternat Med; 2021; 2021():8262502. PubMed ID: 34484405
[TBL] [Abstract][Full Text] [Related]
9. SHCBP1 promotes cisplatin induced apoptosis resistance, migration and invasion through activating Wnt pathway.
Zou A; Wu A; Luo M; Zhou C; Lu Y; Yu X
Life Sci; 2019 Oct; 235():116798. PubMed ID: 31472149
[TBL] [Abstract][Full Text] [Related]
10. Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma.
Peng C; Zhao H; Chen W; Song Y; Wang X; Li J; Qiao Y; Wu D; Ma S; Wang X; Gao C
Oncotarget; 2016 Oct; 7(41):66822-66834. PubMed ID: 27572315
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of SHCBP1 promotes migration and invasion in gliomas by activating the NF-κB signaling pathway.
Zhou Y; Tan Z; Chen K; Wu W; Zhu J; Wu G; Cao L; Zhang X; Zeng X; Li J; Zhang W
Mol Carcinog; 2018 Sep; 57(9):1181-1190. PubMed ID: 29745440
[TBL] [Abstract][Full Text] [Related]
12. Targeting SHCBP1 inhibits cell proliferation in human hepatocellular carcinoma cells.
Tao HC; Wang HX; Dai M; Gu CY; Wang Q; Han ZG; Cai B
Asian Pac J Cancer Prev; 2013; 14(10):5645-50. PubMed ID: 24289556
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of SHCBP1 inhibitor AZD5582 in pancreatic cancer treatment.
Ma Z; Gu Q; Dai Y; Wang Q; Shi W; Jiao Z
Cancer Sci; 2024 Mar; 115(3):820-835. PubMed ID: 38151993
[TBL] [Abstract][Full Text] [Related]
14. Biological functions and therapeutic potential of SHCBP1 in human cancer.
Lin Y; Cai H
Biomed Pharmacother; 2023 Apr; 160():114362. PubMed ID: 36739763
[TBL] [Abstract][Full Text] [Related]
15. EGF-induced nuclear translocation of SHCBP1 promotes bladder cancer progression through inhibiting RACGAP1-mediated RAC1 inactivation.
Yin H; Zhang C; Wei Z; He W; Xu N; Xu Y; Li T; Ren K; Kuang Y; Zhu X; Yuan F; Yu H; Gou X
Cell Death Dis; 2022 Jan; 13(1):39. PubMed ID: 35013128
[TBL] [Abstract][Full Text] [Related]
16. SHCBP1 is over-expressed in breast cancer and is important in the proliferation and apoptosis of the human malignant breast cancer cell line.
Feng W; Li HC; Xu K; Chen YF; Pan LY; Mei Y; Cai H; Jiang YM; Chen T; Feng DX
Gene; 2016 Aug; 587(1):91-7. PubMed ID: 27129942
[TBL] [Abstract][Full Text] [Related]
17. The Role of Shcbp1 in Signaling and Disease.
Zhang GY; Ma ZJ; Wang L; Sun RF; Jiang XY; Yang XJ; Long B; Ye HL; Zhang SZ; Yu ZY; Shi WG; Jiao ZY
Curr Cancer Drug Targets; 2019; 19(11):854-862. PubMed ID: 31250756
[TBL] [Abstract][Full Text] [Related]
18. SHCBP1 contributes to the proliferation and self‑renewal of cervical cancer cells and activation of the NF‑κB signaling pathway through EIF5A.
Deng B; Li A; Zhu Y; Zhou Y; Fei J; Miao Y
Oncol Lett; 2023 Jun; 25(6):246. PubMed ID: 37153055
[TBL] [Abstract][Full Text] [Related]
19. SHCBP1 regulates apoptosis in lung cancer cells through phosphatase and tensin homolog.
Wang F; Li Y; Zhang Z; Wang J; Wang J
Oncol Lett; 2019 Aug; 18(2):1888-1894. PubMed ID: 31423258
[TBL] [Abstract][Full Text] [Related]
20. The dynamic role of nucleoprotein SHCBP1 in the cancer cell cycle and its potential as a synergistic target for DNA-damaging agents in cancer therapy.
Zhou M; Duan L; Chen J; Li Y; Yin Z; Song S; Cao Y; Luo P; Hu F; Yang G; Xu J; Liao T; Jin Y
Cell Commun Signal; 2024 Feb; 22(1):131. PubMed ID: 38365687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
